FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Summary

The aim of this study is to evaluate the safety of the third vaccination with FSME-IMMUN NEW in all volunteers who received both vaccinations in Baxter study 208 (safety study of FSME IMMUN NEW and ENCEPUR in healthy volunteers aged 16 to 65 years).

Timeline

Start

2002-05

Primary completion

—

Completion

2002-08

Drugs

Indications